![Jeffrey L. Blumer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey L. Blumer
No más puestos en curso
Perfil
Jeffrey L.
Blumer is a Director of Encelle, Inc. He is Chief for the Division of Pediatric Pharmacology and Critical Care of Rainbow Babies.
He is a Professor of Pediatrics and Pharmacology for Case Western Reserve University.
He is a Director of the Cleveland Poison Control Center.
He received an MD from Case Western Reserve University and a PhD in Pharmacology from Northwestern University.
Antiguos cargos conocidos de Jeffrey L. Blumer.
Empresas | Cargo | Fin |
---|---|---|
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | Director/Miembro de la Junta | 17/10/2008 |
Formación de Jeffrey L. Blumer.
Case Western Reserve University | Graduate Degree |
Northwestern University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey L. Blumer